Literature DB >> 28820082

High-dose B-vitamin supplements and risk for age-related cataract: a population-based prospective study of men and women.

Jinjin Z Selin1, Birgitta E Lindblad1, Matteo Bottai2, Ralf Morgenstern3, Alicja Wolk1.   

Abstract

Previous studies that have investigated the association between B-vitamin supplement use and risk for cataract yield conflicting results. The aim of this study was to examine the association between use of high-dose B-vitamin supplements (approximately 10 times recommended daily intake) and risk for age-related cataract in a population-based prospective study of 13 757 women from the Swedish Mammography Cohort and 22 823 men from the Cohort of Swedish Men. Dietary supplement use and potential confounders were assessed using a questionnaire at baseline. Information on cataract diagnosis and extraction was obtained through linkage to registers. During the follow-up period between January 1998 and December 2011, we identified 8395 cataract cases (3851 for women and 4544 for men). The use of B vitamins plus other supplements and B vitamins only was associated with 9 % (95 % CI 2, 17) and 27 % (95 % CI 12, 43) increased risk for cataract, respectively. The hazard ratios for use of B vitamins only and risk for cataract stratified by different age groups were as follows: <60 years: 1·88 (95 % CI 1·47, 2·39); 60-69 years: 1·21 (95 % CI 0·96, 1·53); and ≥70 years: 1·09 (95 % CI 0·91, 1·31) (P interaction=0·002). Our results suggest that the use of high-dose B-vitamin supplements was associated with an increased risk for cataract. This association might be confined to younger participants.

Entities:  

Keywords:  HR hazard ratio RCT randomised clinical trial RDI recommended daily intake; B-vitamin supplements; Cataracts; Nutritional epidemiology; Prospective cohort studies

Mesh:

Substances:

Year:  2017        PMID: 28820082     DOI: 10.1017/S0007114517001994

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  1 in total

1.  Lanosterol Synthase Pathway Alleviates Lens Opacity in Age-Related Cortical Cataract.

Authors:  Xinyue Shen; Manhui Zhu; Lihua Kang; Yuanyuan Tu; Lele Li; Rutan Zhang; Bai Qin; Mei Yang; Huaijin Guan
Journal:  J Ophthalmol       Date:  2018-07-11       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.